Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 374

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Pharmacological profile of progestins

Sitruk-Ware, Regine·2004·Maturitas
DOI 10.1016/j.maturitas.2004.01.001
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.maturitas.2004.01.001

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 26

  1. Sitruk-Ware, 2002, Progestogens in HRT: new molecules, Menopause, 9, 6, 10.1097/00042192-200201000-00003 · DOI
  2. Oelkers, 1995, Effects of the new oral contraceptive containing an anti-mineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance and lipid metabolism, J Clin Endocrinol Metab, 80, 1816
  3. Tuba, 2000, Synthesis and biological activity of a new progestogen, 16-methylene-17a-hydroxy-18-methyl-10-norpregn-4ene-3, 20-dione acetate, Steroids, 65, 266, 10.1016/S0039-128X(99)00109-9 · doi:10.1016/s0039-128x(99)00109-9
  4. Paris, 1983, The pharmacological profile of TX 066 (17a-acetoxy-6methyl-19-nor-4, 6-pregna-diene-3, 20-dione) a new oral progestative, Drug Res, 33, 710
  5. Kumar, 2000, Nestorone®: a progestin with a unique pharmacological profile, Steroids, 65, 629, 10.1016/S0039-128X(00)00119-7 · DOI · Paper page
  6. Philibert, 1999, The pharmacological profile of a novel norpregnane progestin (trimegestone), Gynecol Endocrinol, 13, 316, 10.3109/09513599909167574 · DOI
  7. Bullock, 1977, Androgenic, synadrogenic and anti-androgenic actions of progestins, Ann NY Acad Sci., 286, 321, 10.1111/j.1749-6632.1977.tb29427.x · DOI
  8. Duc, 1995, Anti-androgenic properties of nomegestrol acetate, Arzneim Forsch/Drug Res, 45, 70
  9. Hellman, 1976, The effect of medroxyprogesterone acetate on the pituitary-adrenal axis, J Clin Endocrinol Metab, 42, 912, 10.1210/jcem-42-5-912 · DOI
  10. Kuhl H. Comparative pharmacology of newer progestogens. Drugs 1996;51:188–215. · DOI · Paper page
  11. Dusterberg, 1981, Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys, Contraception, 24, 673, 10.1016/0010-7824(81)90018-4 · doi:10.1016/0010-7824(81)90018-4
  12. Fuhrmann, 1996, The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and anti-androgenic potential, Contraception, 54, 243, 10.1016/S0010-7824(96)00195-3 · DOI · Paper page
  13. Pollow, 1991, Dihydrospirorenone (ZK30595), a new progestogen with anti-mineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin–aldosterone system in normal women, J Clin Endocrinol Metab, 73, 837, 10.1210/jcem-73-4-837 · DOI
  14. Ezan, 1993, Enzyme immunoassay for nomegestrol acetate in human plasma, J Steroid Biochem Mol Biol, 46, 507, 10.1016/0960-0760(93)90105-6 · DOI
  15. Noé, 1993, Pharmacokinetics and bioavilability of ST1435 administered by different routes, Contraception, 48, 548, 10.1016/0010-7824(93)90117-P · doi:10.1016/0010-7824(93)90117-p
  16. Oelkers, 1991, Dihydrospirenone, a new progestogen with anti-mineralocorticoid activity: effects on ovulation, electrolyte excretion, and the rennin–aldosterone system in normal women, J Clin Endocrinol Metab, 73, 837, 10.1210/jcem-73-4-837 · DOI
  17. Foidart, 2000, A comparative investigation of contraceptive reliability, Eur J Contracept Reprod Health Care, 5, 124, 10.1080/13625180008500387 · DOI
  18. Huber, 2000, Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone, Eur J Contracept Reprod Health Care, 5, 25, 10.1080/13625180008500375 · DOI
  19. Wiegratz, 2002, Effect of dienogest-containing oral contraceptives on lipid metabolism, Contraception, 65, 223, 10.1016/S0010-7824(01)00310-9 · DOI
  20. Foster, 1998, Dienogest, Drugs, 56, 825, 10.2165/00003495-199856050-00007 · DOI · Paper page
  21. Williams, 1994, Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys, J Am Coll Cardiol, 24, 1757, 10.1016/0735-1097(94)90184-8 · DOI · Paper page
  22. Williams, 1998, Coadministration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses in non human primates, Am J Obstet Gynecol, 179, 1288, 10.1016/S0002-9378(98)70149-8 · DOI
  23. Adams, 1990, Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone, Arteriosclerosis, 10, 1051, 10.1161/01.ATV.10.6.1051 · DOI · Paper page
  24. Kemmeren JM, Algra A, Meijers JCM, Bouma BN, Grobbee DE. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of factor V leaden mutation. Thromb Haemost 2002;87:199–205. · DOI
  25. Lidegaard, 2002, Oral contraceptives and venous thromboembolism: a five-year national case–control study, Contraception, 65, 187, 10.1016/S0010-7824(01)00307-9 · DOI · Paper page
  26. Odlind V, Milsom I, Persson, Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand 2002;81:482–90. · DOI

Cited by

See all 374

Metadata

Authors
Sitruk-Ware, R.
Venue
Maturitas
Publisher
Elsevier BV
Published
2004-04
Volume
47
Issue
4
Pages
277-283
ISSN
0378-5122 (ISSN-L)
DOI
10.1016/j.maturitas.2004.01.001
OpenAlex
W2094220317
Cited by
374
References
2
FWCI
16.91
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacological profile of progestins. https://app.cochat.ai/papers/10.1016/j.maturitas.2004.01.001
The paper
Sitruk-Ware, R. (2004). Pharmacological profile of progestins. Maturitas. https://doi.org/10.1016/j.maturitas.2004.01.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.